Still working to recover. Please don't edit quite yet.
Difference between revisions of "Post-SSRI Sexual Dysfunction"
Anarchangel (Talk | contribs) (Undo revision 45460 by 144.75.132.33 (Talk) Removed IP SPA bad at spelling's assertion that"PEOPLE HERE AT BAD AT SCIENCE") |
|||
| Line 16: | Line 16: | ||
The major pharmaceutical companies are the largest sponsor of the major media networks, which discourages said networks from reporting on the corruption of said pharmaceutical companies, including the concealment of PSSD, corrupt relations with psychiatrists, and the companies' huge profit margins. | The major pharmaceutical companies are the largest sponsor of the major media networks, which discourages said networks from reporting on the corruption of said pharmaceutical companies, including the concealment of PSSD, corrupt relations with psychiatrists, and the companies' huge profit margins. | ||
| − | |||
[[Category:Fraud and deception]] | [[Category:Fraud and deception]] | ||
[[Category:Oppression]] | [[Category:Oppression]] | ||
Revision as of 04:14, 20 December 2010
Post-SSRI Sexual Dysfunction is the SSRI-induced drastic and permanent reduction of a person's capacity for physical sexual pleasure. Post-SSRI Sexual Dysfunction may be abbreviated as PSSD. PSSD occurs in a small fraction of the people that take SSRIs. A higher dosage-to-bodyweight ratio increases the probability of PSSD occurring.
Most of the SSRI chemicals are fluorinated or chlorinated, which means that the enzymes within the human body cannot break them down. That allows SSRIs to accumulate in the body at a high concentration, which is in large part responsible for PSSD. Fluoxetine and paroxetine are fluorinated, whereas sertraline is chlorinated.
PSSD is caused by the permanent epigenetic switch-off of the 5-ht1a receptors in the raphe nuclei, due to the over-stimulation and desensitization of said receptors. The raphe nuclei project serotoninergic axons into the basal ganglia and the nucleus accumbens. The nucleus accumbens is the brain's pleasure center. It is the D1 dopamine receptors of the nucleus accumbens that are responsible for the sensation of pleasure. Sexual pleasure depends not only upon the nucleus accumbens, but also upon the raphe nuclei projections thereto. When the raphe nuclei lack 5-ht1a receptors, the raphe nuclei projections to the nucleus accumbens do not allow the dopamine production that is necessary to create sexual pleasure.
Eli Lily learned of this effect early in the drug testing, but covered it up, and the other pharmaceutical companies followed suit. The absence of any mention of this effect on the warning label constitutes fraud. Company representatives who are aware that SSRIs cause PSSD claim that PSSD is instead caused by depression itself (which people often use SSRIs for), which is a flimsy cover considering that the sexual effects of depression are very different than those caused by PSSD, and the fact that PSSD is statistically more common in people who have used SSRIs for OCD rather than depression. The major pharmaceutical companies are the largest sponsor of the major media networks, which discourages said networks from reporting on the corruption of said pharmaceutical companies, including the concealment of PSSD, corrupt relations with psychiatrists, and the companies' huge profit margins.
